Shares in ResMed (NYSE:RMD) have fallen today despite the respiratory device maker beating expectations on Wall Street with its fiscal year 2018 third quarter earnings release. The San Diego, Calif.-based company posted profits of $110.1 million, or 76¢ per share, on sales of $591.6 million for the three months ended March 31, for bottom-line growth of […]
ResMed Inc.
Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018
Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]
ResMed is disrupting connected health: Here’s how
Here’s how a respiratory firm took control of the connected health and the medtech digital revolution. When you think powerful digital connected devices, the first thing to pop into your head probably isn’t a CPAP. Continuous positive airway pressure has been shown in numerous studies to be effective in improving sleep apnea and preventing a […]
5 medtech stories we missed this week: Jan. 26, 2018
From Attune Medical receiving FDA 510(k) clearance to Synapse Medical having CE Mark approval, here are 5 medtech stories we missed this week but thought were still worth mentioning. 1. Attune Medical gets FDA 510(k) clearance Attune Medical announced in a Jan. 8 press release that it has received FDA 510(k) clearance for its EnsoETM […]
ResMed tops Wall Street’s Q2 earnings forecast, despite $127m tax hit
The U.S. tax reform passed last year dealt a $127 million blow to ResMed (NYSE:RMD) during its fiscal second quarter, but the sleep apnea company still managed to top Wall Street’s consensus earnings forecast with its Q2 results. San Diego-based ResMed posted profits of $9.5 million, or 7¢ per share, on sales of $601.3 million for […]
ResMed lifts on FY2018 Q1 sales beat
Shares in ResMed (NYSE:RMD) have risen in after-hours trading after the medical device maker beat expectations on Wall Street with its 1st quarter fiscal year 2018 earnings results. The San Diego, Calif.-based company posted profits of $86.1 million, or 60¢ per share, on sales of $523.7 million for the 3 months ended September 30, seeing the […]
ResMed claims wins, updates on continuing patent war with Fisher & Paykel
ResMed (NYSE:RMD) this month updated on a number of global patent infringement suits in the UK, Australia and New Zealand as it continues to battle with Fisher & Paykel Healthcare (NZE:FPH). The San Diego, Calif.-based company said that it has decided to proceed with the defense of 1 of 3 UK ResMed patents that were challenged by […]
ResMed touts win in German patent spat with Fisher & Paykel
ResMed (NYSE:RMD) this week touted a win in a patent spat with Fisher & Paykel Healthcare (NZE:FPH) after a German court determined that its AirSense 10, AirCurve 10 and Lumis devices and included humidifiers do not infringe on a Fisher & Paykel patent. The decision was made by the Munich District Court, the San Diego, Calif.-based company said. […]
ResMed shares drop on Q4, FY2017 earnings release
Shares in ResMed (NYSE:RMD) fell today after the respiratory medical device maker posted 4th quarter and and fiscal year 2017 earnings that mostly came out on-top of Wall Street analyst’s expectations, but saw profits shrink nearly 3% compared to the previous year. The San Diego, Calif.-based company posted profits of $101.6 million, or 70¢ per share, […]
Philips, ResMed tout collaborative home ventilation therapy COPD study results
Royal Philips (NYSE:PHG) and ResMed (NYSE:RMD) today touted results from a collaboratively-supported clinical trial exploring the use of home noninvasive ventilation with oxygen therapy on patients with chronic obstructive pulmonary disorder, which indicated improved survivability and prolonged time to readmission. Results from the study were published today in the Journal of the American Medical Association. “Patients […]
ResMed Shares dip on Q3 release despite meeting EPS expectations
ResMed (NYSE:RMD) saw shares fall today in after hours trading after the medical device maker posted 3rd quarter earnings that met earnings per share expectations, but fell short on revenue. The San Diego-based company posted profits of $87.8 million, or 62¢ per share, on sales of $514.2 million for the 3 months ended March 31, for […]
